GAD THOMAS (President and Chairman) received a stock award from Y-MABS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/22/2025ACC: 0001415889-25-001878
DirectorOfficer· President and Chairman
Since Sep 2018
+96K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
96K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+32K
Price / share
—
Trade value
—
% of position
17.6%
1/17/2025
181.53K→213.53K
Total
Net shares
+32K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/17/2025 | A · Award | +32K | — | — | 17.6% | 181.53K | 213.53K |
| Total | +32K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
64K shares
Shares
+64K
Strike price
6.16
Held after
64K
Exercisable
—
1/17/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock64K shares | 1/17/2025 | A · Award | +64K | 6.16 | — | 64K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned60K
Common Stock
IndirectShares owned67.68K
Total
127.68K indirect127.68K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 60K | Indirect |
| Common Stock | 67.68K | Indirect |
| Total | 127.68K | 127.68K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported